Check out your Company Bowl for anonymous work chats.
New CEO Announcement
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A
Great news for Precision Bio and for Cell Therapy
Great explanation of our amazing technology!
Third IND for Precision BioSciences!
Amazing news!!
http://glassdoor.com/slink.htm?key=vMHJg
http://glassdoor.com/slink.htm?key=vMHJL
